Regencell Bioscience

RGC

Market cap $7.26B

Overview Fund Activity

14.69 USD

-0.01

0.07%

At close Updated Sep 15, 10:18 AM EDT

1 day

-0.07%

5 days

11.71%

1 month

11.97%

3 months

-75.52%

6 months

2,917.67%

Year to date

11,485.17%

1 year

10,179.92%

5 years

5,216.68%

10 years

5,216.68%

About: Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Employees: 12

Healthcare Drug Manufacturers - Specialty & Generic

0

Funds holding %

of 7,463 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

4,089% more capital invested

Capital invested by funds: $281K [Q1] → $11.8M (+$11.5M) [Q2]

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

160% more funds holding

Funds holding: 5 [Q1] → 13 (+8) [Q2]

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

2.74% more ownership

Funds ownership: 2.58% [Q1] → 5.31% (+2.74%) [Q2]

See Fund Rankings

Financial journalist opinion

The Motley Fool

1 Magnificent Stock-Split Stock Up 157,000% Since Its IPO to Buy in September, and 1 to Absolutely Avoid

Though artificial intelligence (AI) has been the primary S&P 500 (^GSPC -0.69%) catalyst for nearly three years, it's not the only two-word phrase that'll perk up investors on Wall Street. Mentioning "stock splits" is another easy way to garner attention.

1 Magnificent Stock-Split Stock Up 157,000% Since Its IPO to Buy in September, and 1 to Absolutely Avoid

The Motley Fool

1 Magnificent Stock-Split Stock to Buy Hand Over Fist in August and 1 to Absolutely Avoid

For more than three decades, investors have consistently had a next-big-thing technology or trend to captivate their attention and wallets. For instance, artificial intelligence (AI) has been a driving force for Wall Street's major stock indexes for almost three years.

1 Magnificent Stock-Split Stock to Buy Hand Over Fist in August and 1 to Absolutely Avoid

The Motley Fool

1 Magnificent Stock-Split Stock to Buy Hand Over Fist in July and 1 to Completely Avoid

Though artificial intelligence (AI) has been the hottest innovation on Wall Street for well over two years, it's not the only trend that's helped power Wall Street's major stock indexes to record-closing highs. Excitement surrounding stock splits in some of the market's most influential businesses has been pivotal in sending the broader market higher.

1 Magnificent Stock-Split Stock to Buy Hand Over Fist in July and 1 to Completely Avoid

The Motley Fool

Prediction: Wall Street's Latest Stock-Split Stock -- Up 60,120% Year-to-Date -- Is Going to Implode

Since the S&P 500's bull market began in October 2022, no trend has provided a bigger lift to equities than the evolution of artificial intelligence (AI). In Sizing the Prize, the analysts at PwC estimated AI would bolster the worldwide economy to the tune of $15.7 trillion come 2030.

Prediction: Wall Street's Latest Stock-Split Stock -- Up 60,120% Year-to-Date -- Is Going to Implode

This Chinese Herb Stock Is Now Bigger Than Super Micro And Reddit

Regencell Bioscience Holdings Ltd. RGC, a Hong Kong-based biotech startup with no reported revenue, has gained more than 59,000% in 2025.

This Chinese Herb Stock Is Now Bigger Than Super Micro And Reddit

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

As of June 17, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

This stock with no revenue surges 64,000% in a year: find out why

Regencell Bioscience Holdings, a biotech company focused on herbal medicine, has gained over 400% on Monday and over 64,000% in the past year. This growth in stock price is despite the company not having any revenue so far.

This stock with no revenue surges 64,000% in a year: find out why

What Is Going on With Regencell Bioscience (RGC) Stock Today?

Little-known drug manufacturer Regencell Bioscience (NASDAQ: RGC ) saw its shares skyrocket on Tuesday on no apparent catalyst. However, it's possible that the exceptionally distinct business profile — specializing in traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders — caught the attention of speculators.

What Is Going on With Regencell Bioscience (RGC) Stock Today?

See News Rankings

Charts implemented using Lightweight Charts™